Fu M, Lv M, Guo J, Mei A, Qian H, Yang H
Front Immunol. 2025; 16:1550206.
PMID: 40079010
PMC: 11897580.
DOI: 10.3389/fimmu.2025.1550206.
Jacob A, He J, Peck A, Jamil A, Bunya V, Alexander J
Heliyon. 2025; 11(1):e41082.
PMID: 39801970
PMC: 11720936.
DOI: 10.1016/j.heliyon.2024.e41082.
Mangelinck A, Molitor E, Marchiq I, Alaoui L, Bouaziz M, Andrade-Pereira R
PLoS One. 2024; 19(12):e0315980.
PMID: 39729479
PMC: 11676858.
DOI: 10.1371/journal.pone.0315980.
Jiang Z, Wang H, Wang X, Duo H, Tao Y, Li J
J Clin Invest. 2024; 135(1.
PMID: 39480507
PMC: 11684806.
DOI: 10.1172/JCI179874.
Coulombeau R, Selck C, Giang N, Al-Mohammad A, Ng N, Maher A
Immunology. 2024; 174(1):153-166.
PMID: 39444366
PMC: 11652410.
DOI: 10.1111/imm.13870.
A Paradoxical AKT: Exploring the Promise and Challenges of PI3K/AKT/mTOR Targeted Therapies.
Parkman G, Holmen S
J Cancer Immunol (Wilmington). 2024; 6(3):92-99.
PMID: 39381117
PMC: 11460539.
DOI: 10.33696/cancerimmunol.6.089.
Targeting mechanistic target of rapamycin complex 2 attenuates immunopathology in Systemic Lupus Erythematosus.
Ai M, Zhou X, Carrer M, Jafar-Nejad P, Li Y, Gades N
bioRxiv. 2024; .
PMID: 39131369
PMC: 11312597.
DOI: 10.1101/2024.08.01.606069.
Cytosolic protein translation regulates cell asymmetry and function in early TCR activation of human CD8 T lymphocytes.
Gomez-Moron A, Tsukalov I, Scagnetti C, Pertusa C, Lozano-Prieto M, Martinez-Fleta P
Front Immunol. 2024; 15:1411957.
PMID: 39114656
PMC: 11303187.
DOI: 10.3389/fimmu.2024.1411957.
Complex Role of Regulatory T Cells (Tregs) in the Tumor Microenvironment: Their Molecular Mechanisms and Bidirectional Effects on Cancer Progression.
Wang Y, Li J, Nakahata S, Iha H
Int J Mol Sci. 2024; 25(13).
PMID: 39000453
PMC: 11242872.
DOI: 10.3390/ijms25137346.
Proteobacteria impair anti-tumor immunity in the omentum by consuming arginine.
Meza-Perez S, Liu M, Silva-Sanchez A, Morrow C, Eipers P, Lefkowitz E
Cell Host Microbe. 2024; 32(7):1177-1191.e7.
PMID: 38942027
PMC: 11245731.
DOI: 10.1016/j.chom.2024.06.003.
Pharmacodynamic Effect of mTOR Inhibition-based Immunosuppressive Therapy on T- and B-cell Subsets After Renal Transplantation.
Wei X, Weber S, Yin D, Allabauer I, Jobst-Schwan T, Wiesener M
Transplant Direct. 2024; 10(7):e1666.
PMID: 38911271
PMC: 11191901.
DOI: 10.1097/TXD.0000000000001666.
Noncanonical microprotein regulation of immunity.
Nichols C, Do-Thi V, Peltier D
Mol Ther. 2024; 32(9):2905-2929.
PMID: 38734902
PMC: 11403233.
DOI: 10.1016/j.ymthe.2024.05.021.
Deciphering the developmental trajectory of tissue-resident Foxp3 regulatory T cells.
Alvarez F, Liu Z, Bay A, Piccirillo C
Front Immunol. 2024; 15:1331846.
PMID: 38605970
PMC: 11007185.
DOI: 10.3389/fimmu.2024.1331846.
Gut microbiota-derived butyrate restores impaired regulatory T cells in patients with AChR myasthenia gravis via mTOR-mediated autophagy.
He L, Zhong Z, Wen S, Li P, Jiang Q, Liu F
Cell Commun Signal. 2024; 22(1):215.
PMID: 38570836
PMC: 10988943.
DOI: 10.1186/s12964-024-01588-9.
Nutrients: Signal 4 in T cell immunity.
Raynor J, Chi H
J Exp Med. 2024; 221(3).
PMID: 38411744
PMC: 10899091.
DOI: 10.1084/jem.20221839.
Immunotherapeutic approaches for systemic lupus erythematosus: early overview and future potential.
Huang H
Med Rev (2021). 2024; 3(6):452-464.
PMID: 38282801
PMC: 10808868.
DOI: 10.1515/mr-2023-0032.
USP47 inhibits m6A-dependent c-Myc translation to maintain regulatory T cell metabolic and functional homeostasis.
Wang A, Huang H, Shi J, Yu X, Ding R, Zhang Y
J Clin Invest. 2023; 133(23).
PMID: 37788092
PMC: 10688989.
DOI: 10.1172/JCI169365.
Therapeutic potential of TNFR2 agonists: a mechanistic perspective.
Chen Y, Jiang M, Chen X
Front Immunol. 2023; 14:1209188.
PMID: 37662935
PMC: 10469862.
DOI: 10.3389/fimmu.2023.1209188.
Vaccine adjuvant-elicited CD8 T cell immunity is co-dependent on T-bet and FOXO1.
Ivanova D, Thompson S, Klarquist J, Harbell M, Kilgore A, Lasda E
Cell Rep. 2023; 42(8):112911.
PMID: 37516968
PMC: 10577800.
DOI: 10.1016/j.celrep.2023.112911.
A review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinoma.
DeBenedette M, Gamble A, Norris M, Horvatinovich J, Nicolette C
Hum Vaccin Immunother. 2023; 19(2):2220629.
PMID: 37387210
PMC: 10332239.
DOI: 10.1080/21645515.2023.2220629.